iTBS intervention for methamphetamine addiction

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900024405

Enrollment

Unknown

Registered

2019-07-10

Start date

2019-07-24

Completion date

Unknown

Last updated

2019-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Addiction

Interventions

Group1:L-DLPFC iTBS intervention

Group2:sham iTBS group

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1)Meet DSM-5 criteria for substance abuse, (2)aged 18-60 years, (3)junior high school degree or above, (4)consent to attend this study. (5) The drug abuse time is more than one year, the frequency of use is greater than one week, and the monthly use is greater than 1 gram;

Exclusion criteria

Exclusion criteria: (1)Have contraindications to TMS (head trauma, epilepsy or the history of epilepsy, metal implant etc.), (2)psychiatric illnesses, (3)physical ailments, (4)intellectual impairment (IQ<90), (5)received medication treatment recently, (6)received psychoterapy or TMS intervation on the last 6 months.

Design outcomes

Primary

Measure	Time frame
clinical outcomes;EEG signal;neuroimaging;relapse;side effect;physiological (Such as blood, feces, etc);	—

Secondary

Measure	Time frame
Neuropsychological (Such as depression, anxiety, craving);	—

Countries

China

Contacts

Public ContactTifei Yuan

Shanghai Mental Health Center

ytf0707@126.com+86 18614086633

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026